Skip to main content
Log in

Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat

  • Angiotensin Converting Enzyme Inhibition and the Cardiovascular System
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Angiotensin-converting enzyme (ACE) inhibitors decrease blood pressure by reducing systemic vascular resistance. That the peripheral vasodilating properties of ACE inhibitors might not be homogeneously distributed in all vascular beds and might differ from one drug to another has been investigated in the normotensive rat by the pulsed Doppler technique using the active components of four different ACE inhibitors: captopril, enalapril, perindopril, and ramipril.

Systemic (cardiac output and blood pressure) and regional (kidney, mesentery, hindquarter) hemodynamic responses to saline or to cumulative bolus injections (0.01–1 mg/kg) of captopril, enalaprilat, perindoprilat, or ramiprilat were continuously monitored. The effects of successive bolus injections (0.3–300 ng/kg) of angiotensinII were also investigated. The four ACE inhibitors produced an almost complete blockade of plasma angiotensin-II converting-enzyme activity (83%, 100%, 100%, and 100%, respectively), induced dose-dependent decreases in mean blood pressure, did not significantly affect cardiac output, and reduced total peripheral and mesenteric vascular resistances to the same extent. Hindlimb vascular resistance was identically decreased, but to a lower extent than total peripheral resistance by enalaprilat, perindoprilat, and ramiprilat, whereas it was increased by captopril at low doses only. Renal resistance was markedly decreased by the four drugs, and éspecially by captopril. The decreasing rank order for ACE-inhibitor-induced vasodilation is exactly the same (renal>total peripheral=mesenteric >hindlimb vascular resistances) as that of angiotensin-II-induced regional vasoconstriction, indicating that the vasodilator properties of ACE inhibitors are mainly due to angiotensin-II vasomotor tone suppression. None of the investigated compounds significantly affected mesenteric and hindlimb blood flows, except captopril, which lowered the latter significantly. Finally, the four drugs increased renal blood flow markedly.

Thus, the four drugs exhibited different regional vasodilating patterns, those of enalaprilat, perindoprilat, and ramiprilat being almost similar, while that of captopril was different.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Regoli D, Park WK, Rioux F. Pharmacology of angiotensin.Pharmacol Rev 1974; 26:69–123.

    PubMed  Google Scholar 

  2. Heyndrickx GR, Boettcher DH, Vatner SF. Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs.Am J Physiol 1976; 231:1579–1587.

    PubMed  Google Scholar 

  3. Hartley CJ, Cole JS. An ultrasonic pulsed Doppler system for measuring blood flow in small vessels.J Appl Physiol 1974; 37:626–629.

    PubMed  Google Scholar 

  4. Haywood JR, Shaffer RA, Fastenow C, et al. Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.Am J Physiol 1981; 241:H273-H278.

    PubMed  Google Scholar 

  5. Richer C, Doussau MP, Giudicelli JF. Influence of captopril and enalapril on regional vascular α-adrenoceptor reactivity in SHRs.Hypertension 1984; 6:666–674.

    PubMed  Google Scholar 

  6. Richer C, Lefevre-Borg F, Lechaire J, Gomeni C, Gomeni R, Giudicelli JF, Cavero I. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.J Pharmacol Exp Ther 1987; 240:944–953.

    PubMed  Google Scholar 

  7. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung.Biochem Pharmacol 1971; 20:1637–1648.

    Google Scholar 

  8. Richer C, Doussau MP, Giudicelli JF. Systemic and regional hemodynamic profile of five angiotensin I converting enzyme inhibitors in the spontancously hypertensive rat.Am J Cardiol 1987; 59:12D-17D.

    PubMed  Google Scholar 

  9. Becker RHA, Scholkens B. Ramipril: A review of pharmacology.Am J Cardiol 1987; 59:3D-11D.

    PubMed  Google Scholar 

  10. Koike H, Katsuaki I, Miyamoto M, et al. Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ 14,225) on hemodynamics and circulating blood volume in SHR.Hypertension 1980; 2:299–303.

    PubMed  Google Scholar 

  11. Richer C, Doussau MP, Giudicelli JF. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats.Hypertension 1983; 5:312–320.

    PubMed  Google Scholar 

  12. Unger T, Moursi M, Ganten D, et al. Antihypertensive action of the converting enzyme inhibitor perindopril (S 9490-3) in spontaneously hypertensive rats: Comparison with enalapril (MK 421) and ramipril (HOE 498).J Cardiovasc pharmacol 1986; 8:276–285.

    PubMed  Google Scholar 

  13. Laubie M, Schiavi P, Vincent M, et al. Inhibition of angiotensin I-converting enzyme with S940: Biochemical effects, interspecies differences, and role of sodium diet in the hemodynamic effects.J Cardiovasc Pharmacol 1984; 6:1076–1082.

    PubMed  Google Scholar 

  14. Fisken-Olsen MJ, Britton SL, Houck PC, et al. Effects of SQ 20881 and captopril on mesenteric, renal and iliac vasculatures.Am J Physiol 1983; 244:Heart Circ Physiol 13: H313-H319.

    Google Scholar 

  15. Lappe RW, Todt JA, Wendt RL. Graded vasodilation with converting enzyme inhibitors in conscious spontaneously hypertensive rats.J Pharmacol Exp Ther 1985; 235:651–656.

    PubMed  Google Scholar 

  16. Simon AC, Safar ME, Levenson LA, et al. Action of vasodilating drugs on small and large arteries of hypertensive patients.J Cardiovasc Pharmacol 1983; 5:626–631.

    PubMed  Google Scholar 

  17. Simon AC, Levenson JA, Bouthier J, et al. Effects of acute and chronic angiotensin converting enzyme inhibition on large arteries in human hypertension.J Cardiovasc Pharmacol 1985; 7:S45-S51.

    Google Scholar 

  18. Muirhead EE, Folkow B, Byers LW, et al. Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids.Hypertension 1983; 5:1112–1118.

    Google Scholar 

  19. Mc Gowan HM, Vandongen R, Codde JP, Croft KD. Increased aortic PG12 and plasma lyso-PAF in the unclipped one-kidney hypertensive rat.Am J Physiol 1986; 251:H1361-H1364.

    PubMed  Google Scholar 

  20. Gruetter CA, Ryan ET, Lemke SM, et al. Endotheliumdependent modulation of angiotensin II-induced contraction in blood vessels.Eur J Pharmacol 1988; 146:85–95.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richer, C., Doussau, MP. & Giudicelli, JF. Differential systemic and regional hemodynamic profiles of four angiotensin-I converting-enzyme inhibitors in the rat. Cardiovasc Drug Ther 3, 865–872 (1989). https://doi.org/10.1007/BF01869574

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01869574

Key words

Navigation